Anebulo Pharmaceuticals Inc (ANEB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Operating Expenses | 1,340 | 1,664 | 2,761 | 2,544 | 2,494 |
| Operating Income | -1,340 | -1,664 | -2,761 | -2,544 | -2,494 |
| Interest Expense | 60 | 60 | 32 | 0 | 0 |
| Other Income | 49 | 71 | 76 | 63 | -1 |
| Pre-tax Income | -1,351 | -1,654 | -2,716 | -2,481 | -2,496 |
| Net Income Continuous | -1,351 | -1,654 | -2,716 | -2,481 | -2,496 |
| Net Income | $-1,350 | $-1,654 | $-2,717 | $-2,481 | $-2,496 |
| EPS Basic Total Ops | -0.05 | -0.06 | -0.11 | -0.10 | -0.10 |
| EPS Basic Continuous Ops | -0.05 | -0.06 | -0.11 | -0.10 | -0.10 |
| EPS Diluted Total Ops | -0.05 | -0.06 | -0.11 | -0.10 | -0.10 |
| EPS Diluted Continuous Ops | -0.05 | -0.06 | -0.11 | -0.10 | -0.10 |
| EPS Diluted Before Non-Recurring Items | -0.05 | -0.06 | -0.11 | N/A | N/A |
| EBITDA(a) | $-1,281 | $-1,605 | $-2,761 | $-2,544 | $-2,494 |